BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6433078)

  • 1. [Drug resistance of bacteria--the current status and future prospect. 5. Pseudomonas aeruginosa].
    Nishimura T; Takashima T
    Nihon Rinsho; 1984 Mar; 42(3):676-89. PubMed ID: 6433078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiply resistant Pseudomonas aeruginosa in the pediatric field].
    Tabuki K
    Nihon Rinsho; 1991 Oct; 49(10):2387-92. PubMed ID: 1660948
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of aminoglycosides, ureidopenicillins and cephalosporins against P. aeruginosa isolated in Kuala Lumpur.
    Ngeow YS; Puthucheary SD; Lai PS
    Med J Malaysia; 1985 Sep; 40(3):196-201. PubMed ID: 3939567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Thabaut A; Durosoir JL; Meyran M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern aspects of the treatment of Pseudomonas aeruginosa infection].
    Rozhavin MA
    Antibiotiki; 1980 Apr; 25(4):303-7. PubMed ID: 6768339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of antibiotic therapy].
    Tauchnitz C
    Z Gesamte Inn Med; 1973 Feb; 28(4):85-92. PubMed ID: 4349582
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug resistance of bacteria--the current status and future prospect. 4. Serratia].
    Kimura S
    Nihon Rinsho; 1984 Mar; 42(3):671-5. PubMed ID: 6381804
    [No Abstract]   [Full Text] [Related]  

  • 9. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro activity of cefoperazone and penicillins alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Pot CM; Westerdaal NA
    J Antimicrob Chemother; 1981 Aug; 8(2):101-6. PubMed ID: 6456254
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance of Pseudomonas aeruginosa to antimicrobial drugs.
    Sykes RB
    Prog Med Chem; 1975; 12():333-93. PubMed ID: 181789
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity of clinical strains of Ps. aeruginosa to aminoglycoside antibiotics, carbenicillin and their combinations].
    Fomina IP; Kuznetsova SM; Navashin SM
    Antibiotiki; 1970 Dec; 15(12):1094-8. PubMed ID: 4322741
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
    Torres A; Vega J; Aguirre M; Alés JM
    Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-lactamine associations. In vitro synergism and clinical results].
    Acar JF
    Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
    [No Abstract]   [Full Text] [Related]  

  • 18. Some newer antibiotics.
    Kohler RB; Wheat LJ; White AC
    J Indiana State Med Assoc; 1983 Sep; 76(9):573-8. PubMed ID: 6556207
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences in treatment of Pyocyaneus infections of the urinary tract by carbenicillin].
    Gritz K; Naumann P
    Arzneimittelforschung; 1969 Aug; 19(8):1237-41. PubMed ID: 4980238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibacterial activity of tobramycin on Pseudomonas aeruginosa].
    Fleurette J; Flandrois JP
    Nouv Presse Med; 1974 Apr; 3(0):40-2. PubMed ID: 4209337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.